Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)

被引：0
|
作者：
Fonseca, Vivian
Dejager, Sylvie
Albrecht, Diego
Shirt, Lynda
Schweizer, Anja
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [31] Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes (T2DM) and mild hyperglycemia
    Scherbaum, W. A.
    Schweizer, A.
    Mari, A.
    Nilsson, P. M.
    Lalanne, G.
    Jauffret, S.
    Foley, J. E.
    [J]. DIABETES, 2007, 56 : A134 - A134
  • [32] Effect of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) on Lipid Particles in Type 2 Diabetes Mellitus (T2DM)
    Jones, Michael R.
    Ford, Daniel M.
    Baz-Hecht, Merav
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    [J]. DIABETES, 2013, 62 : A302 - A302
  • [33] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Odawara, Masato
    Hamada, Izumi
    Suzuki, Manabu
    [J]. DIABETES THERAPY, 2014, 5 (01) : 169 - 181
  • [34] Efficacy and tolerability of vildagliptin as an add-on to nateglinide in Japanese patients with type 2 diabetes mellitus
    Fujimaki, K.
    Hirose, T.
    Someya, Y.
    Yoshihara, T.
    Fujitani, Y.
    Watada, H.
    [J]. DIABETOLOGIA, 2012, 55 : S357 - S357
  • [35] Vildagliptin as add-on therapy to other oral antidiabetics in Japanese patients with type 2 diabetes
    Suzuki, M.
    Hamada, I.
    Odawara, M.
    [J]. DIABETOLOGIA, 2012, 55 : S354 - S354
  • [36] A single dose of vildagliptin (VILDA) decelerates gastric emptying (GE) in patients with type 2 diabetes (T2DM)
    Woerle, Hans J.
    Lindenberger, Thilo
    Lfnke, Rainer
    Foley, James E.
    Ligueros-Saylan, Monica A.
    Zhang, Yiming
    He, Yan-Ling
    Beglinger, Christoph
    Goeke, Burkhard
    Schirra, Joerg
    [J]. DIABETES, 2007, 56 : A133 - A133
  • [37] Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus
    Kikuchi, Masatoshi
    Haneda, Masakazu
    Koya, Daisuke
    Tobe, Kazuyuki
    Onishi, Yukiko
    Couturier, Andre
    Mimori, Nobuyuki
    Inaba, Yoko
    Goodman, Matthew
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (03) : 216 - 223
  • [38] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Masato Odawara
    Izumi Hamada
    Manabu Suzuki
    [J]. Diabetes Therapy, 2014, 5 : 169 - 181
  • [39] Empagliflozin as Add-on to Linagliptin and Metformin in Patients with Type 2 Diabetes (T2DM): Subgroup Analysis by Region in a 24-Week Randomized Trial
    Wanner, Christoph
    Naderali, Ebrahim
    Maldonaldo, Mario
    Del Parigi, Angelo
    Toorawa, Robert
    Lee, Christopher
    [J]. DIABETES, 2016, 65 : A288 - A289
  • [40] Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent
    Yun-Zhao Tang
    Gang Wang
    Zhen-Huan Jiang
    Tian-Tian Yan
    Yi-Jun Chen
    Min Yang
    Ling-Ling Meng
    Yan-Juan Zhu
    Chen-Guang Li
    Zhu Li
    Ping Yu
    Chang-Lin Ni
    [J]. Diabetology & Metabolic Syndrome, 7
12345